SFM

Sphera Funds Management Portfolio holdings

AUM $479M
1-Year Est. Return 66.44%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+66.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$422M
AUM Growth
+$39.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
127
New
Increased
Reduced
Closed

Top Buys

1
+$23.6M
2
+$13.1M
3
+$7.57M
4
CLBT icon
Cellebrite
CLBT
+$4.7M
5
VRNS icon
Varonis Systems
VRNS
+$4.1M

Top Sells

1
+$15.5M
2
+$8.82M
3
+$8.61M
4
CYTK icon
Cytokinetics
CYTK
+$6.81M
5
TVTX icon
Travere Therapeutics
TVTX
+$6.3M

Sector Composition

1 Healthcare 72.06%
2 Technology 20.2%
3 Industrials 0.82%
4 Consumer Discretionary 0.72%
5 Communication Services 0.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAT icon
101
Applied Materials
AMAT
$295B
– –
-18,000
CGNT icon
102
Cognyte Software
CGNT
$518M
– –
-45,181
CRM icon
103
Salesforce
CRM
$183B
– –
-6,800
CYBR
104
DELISTED
CyberArk
CYBR
– –
-4,000
ELEV
105
DELISTED
Elevation Oncology
ELEV
– –
-328,562
KRYS icon
106
Krystal Biotech
KRYS
$8.06B
– –
-7,335
KZR icon
107
Kezar Life Sciences
KZR
$49.1M
– –
-58,539
MRUS
108
DELISTED
Merus
MRUS
– –
0
MRVL icon
109
Marvell Technology
MRVL
$69.2B
– –
-18,730
MSFT icon
110
Microsoft
MSFT
$2.92T
– –
-11,792
NNDM
111
Nano Dimension
NNDM
$395M
– –
-717,518
NTLA icon
112
Intellia Therapeutics
NTLA
$1.6B
– –
-128,780
NVDA icon
113
NVIDIA
NVDA
$4.31T
– –
-54,515
PANW icon
114
Palo Alto Networks
PANW
$122B
– –
-13,114
RNAM
115
Avidity Biosciences
RNAM
$11.2B
– –
-126,000
S icon
116
SentinelOne
S
$4.46B
– –
-27,000
SLDB icon
117
Solid Biosciences
SLDB
$484M
– –
-50,190
SRPT icon
118
Sarepta Therapeutics
SRPT
$1.76B
– –
-159,323
SRRK icon
119
Scholar Rock
SRRK
$4.52B
– –
-57,497
TLT icon
120
iShares 20+ Year Treasury Bond ETF
TLT
$45.7B
– –
0
TVTX icon
121
Travere Therapeutics
TVTX
$2.67B
– –
-335,333
UBER icon
122
Uber
UBER
$155B
– –
-30,000
VTGN icon
123
VistaGen Therapeutics
VTGN
$23.2M
– –
-447,939
WIX icon
124
WIX.com
WIX
$3.87B
– –
-16,931
XBI icon
125
State Street SPDR S&P Biotech ETF
XBI
$8.13B
– –
0
1 2 3 4
5